EAU Edu Platform on GU cancers
Upcoming event
EAU UROonco: A meeting steered by the EAU Section of Oncological Urology
Home
/
ZIRCON trial and diagnosis ccRCC
Back
ZIRCON trial and diagnosis ccRCC
2024-12-16
In this interview, Dr. Patricia Zondervan (NL) talks to our chief editor Dr. Carmen Mir (ES) about the ZIRCON trial results and the role of girentuximab in decision-making.
Share:
Previous
Next